- 3.9Impact Factor
- 6.8CiteScore
- 18 daysTime to First Decision
Special Issues
Biomedicines publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Emerging Trends in Cancer: Biomarkers, Therapeutic Strategies and Future Directions
Deadline: 31 May 2026
Allergic Rhinitis: From Pathology to Novel Therapeutic Approaches
Deadline: 31 May 2026
Mechanisms of Cellular Senescence and Inflammation in Cardiovascular Disease
Deadline: 31 May 2026
Immunometabolism in Cancer and Autoimmunity: Mechanisms and Therapeutic Targeting
Deadline: 31 May 2026
Recent Advances in Circadian Rhythms
Deadline: 31 May 2026
Advances in Drug Discovery and Development: From Rational Design to Experimental Validation
Deadline: 31 May 2026
Lipid Metabolism and Lipidomics in Human Diseases
Deadline: 31 May 2026
Mitochondrial Dysfunction in Health and Disease: Implications for Cellular Metabolism and Therapeutic Approaches
Deadline: 31 May 2026
New Advances in Chronic Kidney Diseases
Deadline: 31 May 2026
Molecular Mechanisms and Therapeutic Approaches for Oral Disorders: 2nd Edition
Deadline: 31 May 2026
Advances in Pain Management: Exploring Molecular Mechanisms and Novel Therapies
Deadline: 31 May 2026
Innovative Drug Target Discovery in Cancer: From Molecular Mechanisms to Therapeutic Targets
Deadline: 31 May 2026
of 148

